Johnson & Johnson Q3 Preview: Decline in profit is in the cards

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q3 earnings results on Tuesday, October 15th, before market open. Analysts expect a profit of $2.21 per share (-16.9% Y/Y) on …

CouponFollow Extension

9%
OFF

Johnson & Johnson Q3 Preview: Decline In Profit Is In The Cards

3 weeks from now

Johnson & Johnson (NYSE:JNJ) is scheduled to announce Q3 earnings results on Tuesday, October 15th, before market open. Analysts expect a profit of $2.21 per share (-16.9% Y/Y) on …

msn.com

$2.21
OFF

Johnson & Johnson Q3 Preview: Decline In Profit Is In The Cards

3 weeks from now

Oct 15, 2024 · Johnson & Johnson (JNJ) is set to announce Q3 earnings on October 15th. Analysts expect profit of $2.21 on revenue of $22.17B.

seekingalpha.com

7%
OFF

Johnson & Johnson (JNJ) Q3 Earnings Preview: What You Should

3 weeks from now

Oct 10, 2024 · Analysts on Wall Street project that Johnson & Johnson (JNJ) will announce quarterly earnings of $2.19 per share in its forthcoming report, representing a decline of 17.7% …

nasdaq.com

$2.20
OFF

Earnings Preview: Johnson & Johnson Bets On Innovation To Stay In ...

3 weeks from now

Oct 8, 2024 · The market is expecting a mixed outcome – adjusted profit is seen declining year-over-year to $2.20 per share from $2.66 per share in Q3 2023. On the other hand, revenue is …

alphastreet.com

13%
OFF

Johnson & Johnson Q3 EPS Dips On Charges - The Motley Fool

3 weeks from now

Oct 15, 2024 · Johnson & Johnson (JNJ 4.13%) is a global healthcare leader renowned for its pharmaceutical and medical device segments. The Q3 2024 earnings report it released on …

fool.com

7%
OFF

Johnson & Johnson (JNJ) Q3 Earnings Preview: What You

3 weeks from now

Oct 10, 2024 · Analysts on Wall Street project that Johnson & Johnson (JNJ) will announce quarterly earnings of $2.19 per share in its forthcoming report, representing a decline of 17.7% …

tradingview.com

FAQs about Johnson & Johnson Q3 Preview: Decline in profit is in the cards Coupon?

When will Johnson & Johnson (JNJ) announce Q3 earnings?

Johnson & Johnson (NYSE: JNJ) is scheduled to announce Q3 earnings results on Tuesday, October 15th, before market open. Analysts expect a profit of $2.21 per share (-16.9% Y/Y) on revenue of $22.17B (+3.8% Y/Y). The company is expected to post in-line results, as it continues to navigate its MedTech portfolio. ...

Will Johnson & Johnson (JNJ) deliver a year-over-year decline in earnings?

The market expects Johnson & Johnson (JNJ) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2023. ...

Why did Johnson & Johnson lower its Q3 earnings outlook?

Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact 1h Johnson & Johnson (NYSE:JNJ) lowered its full-year earnings outlook on Tuesday despite posting better-than-expected financials for Q3 2024, driven mainly by its pharma unit even as its MedTech division fell short of forecasts. ...

How did Johnson &Johnson (JNJ) perform in the third quarter?

The company's stock rose 1.5% following the announcement. For the third quarter, Johnson&Johnson (NYSE:JNJ) posted adjusted earnings per share of $2.42, surpassing the analyst consensus of $2.19. Revenue came in at $22.5 billion, beating estimates of $22.17 billion and representing a 5.2% increase YoY. ...

Why did Johnson &Johnson raise its full-year operating sales outlook?

Investing.com -- Johnson&Johnson reported third-quarter earnings and revenue that exceeded analyst expectations, prompting the healthcare giant to raise its full-year operational sales outlook. The company's stock rose 1.5% following the announcement. ...

How much Will Johnson &Johnson sell in 2024?

In light of the strong performance, Johnson&Johnson raised its full-year 2024 operational sales guidance. The company now expects operational sales between $89.4 billion and $89.8 billion, up from its prior forecast of $89.2 billion to $89.6 billion. ...